Evidence map›Paper›PMID 32143429›Full record

ArticleBiomolecules2020

Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats.

Shan Shan Qi, Hong Xing Zheng, Hai Jiang, Li Ping Yuan, Le Chen Dong

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shan Shan QiVitamin D Research Institute, College of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, Shaanxi 723000, China.
Hong Xing ZhengCollege of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, Shaanxi 723000, China.
Hai JiangVitamin D Research Institute, College of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, Shaanxi 723000, China.
Li Ping YuanCollege of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, Shaanxi 723000, China.
Le Chen DongCollege of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, Shaanxi 723000, China.
Shaanxi University of Technology · CN

Funding

Shaanxi Agricultural Science and Technology Research Project 2017NY-082Shaanxi University of Technology Postdoctoral Program SLGBH16-03
6 · The paper itself

Abstract

Diabetic nephropathy (DN) is one of the most important complications of diabetes, and the leading cause of end-stage renal disease (ESRD). While Chromium picolinate (CrPic) supplementation has been found to be effective in treating diabetes, its effects on diabetic-induced nephropathy have not been studied. Therefore, in this study, CrPic (1 mg kg

Indexed as

AnimalsBiomarkersDiabetes Mellitus, ExperimentalDiabetic NephropathiesFibrosisGene Expression RegulationMaleOxidative StressPicolinic AcidsRatsRats, Sprague-DawleyBiomarkerspicolinic acidPicolinic Acidsantioxidative stresschromium picolinatediabetic nephropathyrenal fibrosis

Identifiers

PMID32143429
PMCPMC7175215
OpenAlexW3009808558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.